Over‐activation of mGluR5 is reported to be associated with cognitive impairment in APP/PS1 male mice (Hamilton et al., 2016), and excessive mGluR5 signalling activation is restricted to early stages of the disease (Abd‐Elrahman et al., 2020). Here, GRM5 is linked to Cognitive impairment.